1. A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies. Issue 80 (30th August 2016) Authors: Rudd, Stacey E.; Roselt, Peter; Cullinane, Carleen; Hicks, Rodney J.; Donnelly, Paul S. Journal: Chemical communications Issue: Volume 52:Issue 80(2016) Page Start: 11889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bifunctional 64Cu-labelled macrobicyclic cage amine isothiocyanates for immuno-positron emission tomography. Issue 11 (29th October 2014) Authors: Paterson, Brett M.; Buncic, Gojko; McInnes, Lachlan E.; Roselt, Peter; Cullinane, Carleen; Binns, David S.; Jeffery, Charmaine M.; Price, Roger I.; Hicks, Rodney J.; Donnelly, Paul S. Journal: Dalton transactions Issue: Volume 44:Issue 11(2015) Page Start: 4901 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Correction: A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies. Issue 77 (9th September 2016) Authors: Rudd, Stacey E.; Roselt, Peter; Cullinane, Carleen; Hicks, Rodney J.; Donnelly, Paul S. Journal: Chemical communications Issue: Volume 52:Issue 77(2016) Page Start: 11603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Imaging of hypoxia with 18F‐FAZA PET in patients with locally advanced non‐small cell lung cancer treated with definitive chemoradiotherapy. Issue 4 (14th June 2013) Authors: Trinkaus, Mateya E; Blum, Rob; Rischin, Danny; Callahan, Jason; Bressel, Mathias; Segard, Tatiana; Roselt, Peter; Eu, Peter; Binns, David; MacManus, Michael P; Ball, David; Hicks, Rodney J Journal: Journal of medical imaging and radiation oncology Issue: Volume 57:Issue 4(2013:Aug.) Page Start: 475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with 89Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol. Issue 11 (18th November 2022) Authors: Hegi-Johnson, Fiona; Rudd, Stacey E; Wichmann, Christian; Akhurst, Tim; Roselt, Peter; Trinh, Jenny; John, Thomas; Devereux, Lisa; Donnelly, Paul S; Hicks, Rod; Scott, Andrew M; Steinfort, Daniel; Fox, Stephen; Blyth, Benjamin; Parakh, Sagun; Hanna, Gerard G; Callahan, Jason; Burbury, Kate; MacMa... Journal: BMJ open Issue: Volume 12:Issue 11(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗